AI shows potential against resistant bacteria
Machine learning can speed up antibiotic design, but developers struggle to attract investors
Related reading
AI-designed antibodies promise big boost to drug development
University of Washington team uses generative AI tool to create new functional cancer antibodies
How AI can recode the difficult process of drug discovery
Research organisations are banking on technology to help improve the odds of approval
How can we tell good AI from bad?
More lessons from the jagged frontiers of new technology
AI has an Awful Image problem
Modern-day Luddites are gaining ground because tech titans haven’t shown people how innovation will improve their lives
AI is opening up nature’s treasure chest
Creating a machine-readable scientific database of species could deepen our understanding of the natural world
AI mania hits security software M&A
More artificial intelligence means more data, and the potential for more sophisticated threats